Table 3.

Patterns of first progression

Site of failuren = 29
No progression after hypofractionated radiotherapy6/29 (21%)
Progression in treated sites only6/29 (21%)
Progression in treated sites and distant site with known cancer involvement1/29 (3.5%)
Progression in distant sites16/29 (55%)
Progression in sites not previously involved with cancer8/29 (27.6%)
Progression in sites previously involved with cancer6/29 (21%)
Progression in sites previously involved with cancer and in uninvolved sites2/29 (7%)